- Home
- ABSI vs BFS Comparison
ABSI vs BFS Comparison
Compare ABSI & BFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ABSI | BFS |
|---|---|---|
| Founded | 2011 | 1993 |
| Country | United States | United States |
| Employees | N/A | 98 |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 997.8M | 902.2M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | ABSI | BFS |
|---|---|---|
| Price | $8.22 | $35.82 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | $6.96 | ★ $44.00 |
| AVG Volume (30 Days) | ★ 7.7M | 99.3K |
| Earning Date | 05-07-2026 | 05-11-2026 |
| Dividend Yield | N/A | ★ 6.92% |
| EPS Growth | ★ 10.64 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,534,000.00 | N/A |
| Revenue This Year | $215.96 | $0.30 |
| Revenue Next Year | $319.10 | $5.67 |
| P/E Ratio | ★ N/A | $30.48 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.24 | $29.16 |
| 52 Week High | $12.06 | $38.42 |
Technical Indicators
Market Signals| Indicator | ABSI | BFS |
|---|---|---|
| Relative Strength Index (RSI) | 42.86 | 45.45 |
| Support Level | $2.56 | $35.32 |
| Resistance Level | $12.06 | $38.25 |
| Average True Range (ATR) | 0.76 | 0.74 |
| MACD | -0.49 | -0.11 |
| Stochastic Oscillator | 14.93 | 22.49 |
Price Performance
Historical ComparisonAbout ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.
About BFS Saul Centers Inc.
Saul Centers Inc is a self-managed real estate investment trust which invests in, operates and develops retail and commercial properties. The company's portfolio includes community and neighbourhood shopping centres, office properties, and mixed-use properties. Properties are located in the Washington, D.C. and Batlimore metropolitan areas. Saul Centers operates through two business segments: Shopping Centers segment, which contribute the maximum portion of total revenue; and mixed-use properties.Mixed-Use Properties segment include office, retail and multi-family residential use.